Trapeziometacarpal Prosthesis vs. Resection-Interposition Arthroplasty

Sponsor
Medical University of Graz (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05267964
Collaborator
Stryker Instruments (Industry)
100
2
89

Study Details

Study Description

Brief Summary

Rhizarthrosis is a frequently occurring pathology leading to severe limitations in daily life due to pain and loss of function. Good clinical results have been reported for some carpometacarpal (CMC) joint prosthesis designs, but high failure rates due to loosening and dislocation must be considered. The study aim was to investigate a new, double mobility CMC-prosthesis design with special focus on (1) the functional outcome and (2) patient quality of life (QOL)

Condition or Disease Intervention/Treatment Phase
  • Procedure: Epping resection arthroplasty
  • Procedure: CMC I prosthesis
N/A

Detailed Description

The Epping resection-suspension arthroplasty procedure was described in 1983 to address the proximal migration of the first ray while providing pain free grip strength without any implants. It has shown rather good functional outcome and pain relief. A reduction in thumb opposition strength of 27% compared to the contralateral side and intermittent pain in physical activity is reported, however. Further, studies comparing trapeziectomy and trapeziectomy with tendon interposition recommend trapeziectomy due to the simple technique and comparable outcome.

Endoprosthesis of the first carpometacarpal (CMC) joint represents a different treatment strategy aiming at an exact reconstruction of the joint geometry. Some studies report excellent functional outcome and pain relief. However, there are some prosthesis designs (cemented and uncemented) with high rates of loosening, luxation and poor subjective results. To address these issues, a prosthesis was designed combining a cylindric, double mobility cup and a hydroxyapatite covered stem and cup available in different sizes. The aim of this study was to compare this new prosthesis design to the Epping arthroplasty as the current standard in the investigator's institution regarding (1) the functional outcome with special focus on mobility and strength and (2) patient quality of life (QOL) and pain relief.

Note: The registration of this trial on Clinicaltrials.gov was carried out retrospectively after primary completion of the study.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Masking Description:
Patients are radomized into two groups prior to the surgical intervention using the radomizing programm of the medical university of graz.
Primary Purpose:
Treatment
Official Title:
Trapeziometacarpal Prosthesis vs. Resection-Interposition Arthroplasty A Randomized Controlled Trial
Actual Study Start Date :
Nov 1, 2014
Actual Primary Completion Date :
Nov 30, 2019
Anticipated Study Completion Date :
Apr 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Epping resection arthroplasty

During the Epping resection-suspension arthroplasty the trapeziectomy is performed, the flexor carpi radialis tendon is divided into two parts and one of these is stripped and cut proximally. To prevent shortening of the first ray with following loss of strength, this tendon strip is pulled through a drill hole in the base of the 1st metacarpal from ulnar palmar to radial dorsal. The rest of the tendon strip is sutured to a roll replacing the os trapezium.

Procedure: Epping resection arthroplasty
Follwing the described epping resection arthroplasty, The first ray was immobilized using an orthosis for four weeks postoperatively in both study groups followed by eight weeks of physical therapy.

Active Comparator: CMC I prosthesis group

During implantation of the prosthesis the CMC joint is opened and 3 mm of the metacarpal base as well as osteophytes are resected. Following the release of the trapezium the first metacarpal and the trapezium are prepared for the prosthesis by broaching and drilling. After the test-implants have shown satisfying joint tension and anatomic conditions, the HA coated stem and cup are pressfit inserted in the appropriate size followed by the modular head.

Procedure: CMC I prosthesis
Follwing the described CMC I prosthesis procedure, The first ray was immobilized using an orthosis for four weeks postoperatively in both study groups followed by eight weeks of physical therapy.

Outcome Measures

Primary Outcome Measures

  1. Functional outcome- Thumb opposition [twelve months postoperative]

    Measurement of thumb opposition (scale from 1 to 10) range according to Kapandji. A score of 0 indicates no opposition, a score of 10 indicates maximal opposition.

  2. Functional outcome - Thumb retropulsion [twelve months postoperative]

    Measurement of thumb retropulsion (scale from 1 to 3) range according to Kapandji

  3. Functional outcome - maximal palmar abduction [twelve months postoperative]

    measurement of the maximal palmar abduction using a goniometer.

  4. Functional outcome - maximal radial abduction [twelve months postoperative]

    measurement of the maximal radial abduction using a goniometer.

  5. Functional outcome - tip-to-tip force [twelve months postoperative]

    The tip-to-tip force (between thumb and index finger) was measured in Newton (N) using a handheld dynamometer (Cit Technics, Haren, Netherlands).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • symptomatic rhizarthrosis grade 2 and 3 according to Eaton's classification,

  • failed conservative treatment prior to surgery,

  • written informed consent to the study.

Exclusion Criteria:
  • scaphotrapezotrapezoidal (STT) arthrosis,

  • former CMC joint surgery,

  • patients under custodianship.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Medical University of Graz
  • Stryker Instruments

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Medical University of Graz
ClinicalTrials.gov Identifier:
NCT05267964
Other Study ID Numbers:
  • 26-543 ex 13/14
First Posted:
Mar 7, 2022
Last Update Posted:
Mar 7, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 7, 2022